Buy Cagrilintide — USA-Made, COA per Lot
Cagrilintide is a novel, long-acting acylated amylin analogue designed for laboratory evaluation of metabolic signaling, satiety pathways, and neuroendocrine regulation. PX1 Research supplies high-purity, USA-synthesized cagrilintide strictly for in vitro and preclinical research applications. Every batch undergoes rigorous HPLC and mass spectrometry verification at independent ISO 17025 accredited testing facilities.
Quick answer
Cagrilintide is a novel, long-acting acylated amylin analogue designed for laboratory evaluation of metabolic signaling, satiety pathways, and neuroendocrine regulation. PX1 Research supplies high-purity, USA-synthesized cagrilintide strictly for in vitro and preclinical research applications. Every batch undergoes rigorous HPLC and mass spectrometry verification at independent ISO 17025 accredited testing facilities.
Key takeaways
- [Cagrilintide](/research-peptides/cagrilintide) is a non-selective, long-acting synthetic agonist of the amylin receptor family, engineered to mimic endogenous amylin (islet amyloid polypeptide).
- In vitro functional assays demonstrate that [cagrilintide](/research-peptides/cagrilintide) acts as a potent agonist across all three amylin receptor subtypes (AMY1, AMY2, and AMY3), as well as the uncomplexed calcitonin receptor.
- The integrity of preclinical data depends entirely on the chemical purity and structural fidelity of research reagents.
- PX1 Research enforces a zero-compromise analytical protocol for every lot of [cagrilintide](/research-peptides/cagrilintide).
Pharmacological Profile and Structural Features of Cagrilintide
Cagrilintide is a non-selective, long-acting synthetic agonist of the amylin receptor family, engineered to mimic endogenous amylin (islet amyloid polypeptide). Structure-activity relationship studies indicate that cagrilintide incorporates fatty acid acylation, a modification that extends its biological half-life by facilitating reversible binding to serum albumin. This modification enables sustained receptor engagement across multi-day preclinical assay protocols without requiring frequent redosing.
Endogenous amylin co-secretes with insulin from pancreatic beta cells in response to nutrient intake. In animal models, cagrilintide targets pancreatic and central neuroendocrine receptors, specifically engaging the calcitonin receptor (CTR) core subunits when heterodimerized with receptor activity-modifying proteins (RAMP1, RAMP2, and RAMP3). Researchers utilizing cagrilintide for preclinical models can evaluate its unique receptor activation kinetics compared to native pancreatic peptides.
Preclinical Mechanisms: Dual Amylin and Calcitonin Receptor Agonism
In vitro functional assays demonstrate that cagrilintide acts as a potent agonist across all three amylin receptor subtypes (AMY1, AMY2, and AMY3), as well as the uncomplexed calcitonin receptor. Binding to these GPCR complexes triggers intracellular cyclic adenosine monophosphate (cAMP) accumulation, downstream phosphorylation of signal-regulated kinases, and activation of central satiety circuits located within the area postrema and the nucleus of the solitary tract (NTS).
Preclinical rodent literature documents that activation of these hindbrain structures leads to marked reductions in voluntary food intake, delayed gastric emptying rates, and alterations in energy expenditure dynamics. Because cagrilintide acts independently of the glucagon-like peptide-1 (GLP-1) pathway, it represents a crucial tool in metabolic research literature for dissecting complementary, non-GLP-1 mediated pathways in metabolic homeostasis.
Why Sourcing USA-Synthesized Cagrilintide Matters for Data Reproducibility
The integrity of preclinical data depends entirely on the chemical purity and structural fidelity of research reagents. Overseas peptide manufacturers frequently utilize low-cost solid-phase peptide synthesis (SPPS) protocols that skip essential purification steps, resulting in batches contaminated with truncated peptide sequences, deletion sequences, residual trifluoroacetic acid (TFA) salts, and heavy metal catalysts.
Unregulated peptide imports often fail to maintain temperature control during international transit, leading to peptide aggregation and loss of secondary structure. PX1 Research mitigates these risks by manufacturing all research peptides domestically in GMP-compliant USA facilities. Domestic synthesis permits strict control over amino acid coupling efficiency, resin cleavage, and preparative HPLC purification, guaranteeing batch-to-batch consistency for institutional research programs. Principal investigators planning larger study volumes can review options for institutional account procurement to ensure long-term supply stability.
PX1 Research Quality Verification: HPLC, Mass Spectrometry, and ISO 17025 Integrity
PX1 Research enforces a zero-compromise analytical protocol for every lot of cagrilintide. Prior to release, samples are submitted to independent, third-party ISO 17025 accredited laboratories where they undergo High-Performance Liquid Chromatography (HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS).
HPLC testing confirms chromatographic purity, verifying that the main peptide peak exceeds the standard research benchmark (typically ≥98.0%), with minimal baseline noise or synthetic impurities. ESI-MS verifies the exact monoisotopic molecular weight, confirming correct primary sequence assembly and acylation without unexpected chemical modifications. Principal investigators can download lot-specific Certificates of Analysis (COAs) directly from PX1 Research prior to commencing laboratory protocols.
Endotoxin Testing Protocols for Cell Culture and In Vivo Models
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—are common contaminants in peptide synthesis and purification reagents. In cell culture models, endotoxins induce non-specific inflammatory cytokine release (such as TNF-alpha and IL-6), distorting signal transduction data. In animal models, endotoxins elicit pyrogenicity, immune activation, and metabolic alterations completely unrelated to the peptide under investigation.
Every batch of cagrilintide from PX1 Research undergoes strict quantitative endotoxin testing via the Chromogenic Limulus Amebocyte Lysate (LAL) assay. We enforce stringent threshold limits (<0.01 EU/mg), ensuring that research compounds introduced into sensitive primary cell cultures, organoid models, or rodent assays produce clean, unconfounded empirical results.
Comparative Analysis: Cagrilintide vs. GLP-1 and Multi-Incretin Agonists
Understanding how cagrilintide compares to other metabolic research compounds is critical when designing comparative or combination assay protocols. While single-target GLP-1 receptor agonists such as semaglutide focus primarily on pancreatic insulin secretion and hypothalamic GLP-1R signaling, cagrilintide operates via distinct amylin/calcitonin receptor pathways in the hindbrain. Dual incretin agonists like tirzepatide combine GLP-1 and GIP activity, whereas triple agonists like retatrutide incorporate glucagon receptor activation to elevate energy expenditure.
Preclinical co-administration studies demonstrate that combining an amylin agonist like cagrilintide with a GLP-1 receptor agonist yields synergistic reductions in cumulative food intake and body mass in rodent models. This synergistic response suggests that amylin pathway signaling acts via distinct neuronal subpopulations in the brainstem that complement forebrain GLP-1 circuits. Researchers investigating dual-pathway metabolic regulation frequently evaluate cagrilintide alongside these incretin mimetics to map convergent neuroendocrine signaling cascades.
Laboratory Handling, Reconstitution, and Storage Specifications
Cagrilintide is supplied as a sterile, lyophilized cake or powder inside high-recovery borosilicate glass vials sealed under inert nitrogen atmosphere. Proper handling protocols must be observed to maintain peptide stability and prevent physical denaturation upon receipt at the laboratory facility.
For optimal shelf-life, lyophilized cagrilintide should be stored in a dark, desiccated environment at -20°C or -80°C. Prior to reconstitution, vials should be allowed to equilibrate to room temperature to prevent atmospheric moisture condensation inside the container. Depending on experimental parameters, reconstitution should be performed using sterile Bacteriostatic Water or an appropriate buffer. Detailed instructions regarding solubility, pH optimization, and aliquot storage can be reviewed in our peptide reconstitution guide.
Fulfillment Excellence: Rapid Dispatch from USA Logistics Hubs
PX1 Research understands that research timelines depend on reliable reagent delivery. To prevent experimental delays caused by extended supply chain bottlenecks, PX1 operates dedicated fulfillment facilities located in California and Arizona.
Orders for cagrilintide 5mg vials confirmed before cut-off times ship the same day (Monday through Friday). All shipments utilize temperature-controlled protective packaging designed to buffer against ambient temperature spikes during transit, ensuring that researchers receive compounds maintaining full bioactivity and structural integrity.
Frequently Asked Questions
What is the purity level of cagrilintide supplied by PX1 Research?
PX1 Research supplies cagrilintide synthesized to a minimum target purity of ≥98.0% as determined by High-Performance Liquid Chromatography (HPLC) analytical testing.
How does PX1 Research verify the identity and purity of cagrilintide?
Every production lot undergoes independent third-party analytical verification at an ISO 17025 accredited laboratory using HPLC for purity profiling and Mass Spectrometry (MS) for sequence and mass confirmation.
What endotoxin limits are maintained for cagrilintide lots?
Cagrilintide batches undergo quantitative Limulus Amebocyte Lysate (LAL) testing to ensure bacterial endotoxin levels remain below strictly controlled laboratory research thresholds (<0.01 EU/mg).
How quickly does PX1 Research ship cagrilintide orders?
All orders placed Monday through Friday before our standard cutoff times ship same-day from our dual logistics hubs located in California and Arizona.
How should cagrilintide be stored upon arrival at the facility?
Lyophilized cagrilintide should be stored at -20°C or lower in a dry, dark location. Once reconstituted, solution aliquots should be kept refrigerated at 2°C to 8°C for short-term use or frozen at -80°C to avoid repeated freeze-thaw cycles.
Which solvent is recommended for reconstituting cagrilintide in vitro?
Reconstitution preferences depend on assay design; however, standard sterile Bacteriostatic Water, sterile 0.9% Sodium Chloride, or suitable laboratory buffers (e.g., dilute acetic acid/PBS systems) are frequently utilized based on desired concentration and pH.
What receptor targets does cagrilintide selectively engage?
Cagrilintide acts as a non-selective agonist at calcitonin receptors (CTR) and amylin receptor complexes (AMY1, AMY2, AMY3), which consist of CTR heterodimerized with Receptor Activity-Modifying Proteins (RAMP1, RAMP2, RAMP3).
Is PX1 Research cagrilintide approved for human clinical administration?
No. Cagrilintide provided by PX1 Research is strictly synthesized for laboratory research, in vitro assays, and animal models. It is not for human, clinical, therapeutic, or diagnostic use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.